摘要
目的为评价合理投入与控制流行性腮腺炎目标的卫生经济学效益。方法对天津市某区2005年1～6月的流行性腮腺炎爆发进行分析。随机抽取就诊的小学生流行性腮腺炎患者161例,结合治疗情况,电话调查其相应的家庭经济损失(包括直接和间接的经济损失)。结果接种1剂次MMR与2剂次MMR的成本—效益比(即:接种MMR三联疫苗的成本与患病后损失的直接和间接费用之比)分别为1∶2.38和1∶1.23。结论MMR疫苗对于预防流行性腮腺炎,不仅具有一定的社会效益,而且显示出经济效益优势。
Objectives In order to evaluate the hygienic and economic benefit of Mumps control. Methods We analyze the outbreak of Mumps in Tianjin from January,2005 to June,2005. First of all,we chose 161 pupils who infect Mumps in random,and then,relating with the therapeutic condition,we investigate the economic losses which includes direct and indirect economic losses. Results The proportion of cost and benefit are 1 ： 2.38 and 1 ： 1.23 respectively. The difference between t hem is that the former has one inoculation, t he latter has two times. Conclusions For preventing Mumps, MMR vaccine can demonstrate specified preponderance of economic performance.
出处
《中国公共卫生管理》
2007年第6期522-524,共3页
Chinese Journal of Public Health Management
关键词
流行性腮腺炎
卫生经济
成本效益
Mumps
Hygienic economy
Analysis on cost and benefit
